A Study of Biomarkers of Kidney Function in Neuroblastoma Survivors

Full Title

Biomarkers of Renal Dysfunction in Neuroblastoma Survivors

Purpose

Chemotherapy and radiation treatment for neuroblastoma, a cancer that in children, can damage the kidneys. The main purpose of this study is to learn more about “biomarkers” of kidney function in the blood and urine of neuroblastoma survivors.

A biomarker is a biological molecule found in blood, urine, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may also be used to see how well the body responds to a treatment for a disease or condition. Participants will provide urine and blood samples to be analyzed to identify new biomarkers of kidney function.

Eligibility

This study is for survivors of neuroblastoma who were diagnosed at age 18 or younger and are under 21 at the time of entering the study. They will have completed treatment at least two years before entering the study.

For more information about this study, please contact Dr. Danielle N. Friedman at 212-639-7376.

Protocol

19-160

Disease Status

Newly Diagnosed & Relapsed/Refractory

Co-Investigators

Gajjar, Anuradha, MD
Kumar, Juhi, MD